GT Biopharma (GTBP) had the highest return between 2008 and 2013 by a US stock in the Nasdaq Composite (IXIC), returning 131,749,985%.

ASSET	YEARS	% RETURN
GT Biopharma (GTBP)	2008-2013	131,749,985%
Nutex Health (NUTX)	2008-2013	749,900.2%
Pioneer Power Solutions (PPSI)	2008-2013	20,520.38%
Weatherford International (WFRD)	2008-2013	10,400%
Future Fintech (FTFT)	2008-2013	6,900%
Altisource Portfolio Solutions (ASPS)	2008-2013	2,945.05%
Nova Lifestyle I (NVFY)	2008-2013	2,906.67%
Clearfield (CLFD)	2008-2013	2,462.03%
eGain (EGAN)	2008-2013	2,175.56%
LifeMD (LFMD)	2008-2013	2,066.67%
Mitek Systems (MITK)	2008-2013	1,463.16%
Predictive Oncology (POAI)	2008-2013	1,381.48%
Where Food Comes From (WFCF)	2008-2013	1,328.6%
Netflix (NFLX)	2008-2013	1,286.18%
DarioHealth (DRIO)	2008-2013	1,250%
N2OFF (NITO)	2008-2013	1,150%
Barfresh Food (BRFH)	2008-2013	1,140%
VerifyMe (VRME)	2008-2013	1,085%
Regeneron Pharmaceuticals (REGN)	2008-2013	1,045.88%
8x8 Inc Common Stock (EGHT)	2008-2013	968.42%
Puma Biotechnology (PBYI)	2008-2013	935.3%
Amneal Pharmaceuticals, Inc Class A Common Stock (AMRX)	2008-2013	905.6%
BioLife Solutions (BLFS)	2008-2013	900%
Booking (BKNG)	2008-2013	895.63%
HealthStream (HSTM)	2008-2013	840.22%